10x Genomics, Inc.

US$59.28As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TXGHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 2.31%
Div yield —
ROE (8.27%)
Medical Devices
Beta (5Y) 2.03
PE TTM —
TSR TTM 334.60%
Mkt cap US$7.797B
ROIC (4.60%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$66
11.96%
(71.24%)
Hold 10|2|3|12|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.07
1.13
1.17
1.20
10.21%
9.56%
8.08%
12.71%
Revenue$M
863.5
898.4
904.1
913.1
14.28%
12.99%
9.28%
9.58%
Peers (US$7.797B)
Cap (US$)
PE
10.16B
23.90x
9.412B
17.50x
9.363B
—
7.903B
32.38x
Capital
TTM
5Y
10Y
Leveragex
0.695
(0.141)
(0.139)
EBIT/Intx
1.320
0.221
0.211
Own earn%
27.32
(5.20)
(4.61)
Sh yield%
33.63
44.30
45.38
Owners
Insiders/Inst%
5.90
58.36
Short interest%
1.01
SBC / revenue%
0.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
10–14
$1 testx
−0.1
Incr. ROIC%
17